- Summits
- Sponsorship
- News
- About
As healthcare systems worldwide continue to face mounting administrative pressure, Luminai, a healthcare-focused AI automation platform, has announced a $38 million Series B funding round, marking a major step forward in the use of artificial intelligence to modernize operational workflows across provider organizations.
The funding round, which brings the company’s total capital raised to $60 million, was led by Peak XV Partners, with participation from Define Ventures and continued support from existing investors, including General Catalyst and Y Combinator.
The fresh capital comes at a time when health systems are under increasing strain from rising operational costs, workforce shortages, and complex administrative processes. Across the industry, administrative functions are estimated to account for up to a quarter of total healthcare spending, underscoring the urgency for scalable and intelligent automation solutions.
Unlike narrow point solutions that address isolated tasks, Luminai is positioning itself as a broader orchestration layer for healthcare operations. Its AI-native platform is designed to process fragmented and unstructured data, interpret operational context, and automate end-to-end workflows across functions such as patient access, revenue cycle management, compliance, and referrals.
“What stands out about Luminai is their platform approach to a historically fragmented problem,” said Shailendra Singh, Managing Partner at Peak XV Partners. “Luminai is building the intelligent orchestration layer that will define how healthcare operations function in the future.”
At the center of the company’s vision is the belief that healthcare administration should no longer depend on manual coordination between disconnected systems. Founder and CEO Kesava Kirupa Dinakaran said recent advances in AI are making it possible to automate full workflows rather than isolated tasks.
“Healthcare’s administrative functions operate as a massive, manual coordination layer,” Dinakaran said. “Recent advances in AI have made it possible to handle that complexity directly and execute full workflows reliably. Luminai is building the AI-native platform designed for the realities of large health systems, one that learns from operational context and improves as conditions evolve. This round enables us to scale that foundation to meet the growing demand of our health system partners.”
Luminai’s team brings together AI and engineering talent from companies such as Google, Palantir Technologies, Coinbase, and Brex, alongside healthcare operators and product leaders with experience from Epic Systems and Banner Health. This blend of technical expertise and healthcare operational insight has helped the company build solutions tailored for regulated, high-stakes environments.
According to the company, the platform has already driven more than 12 million automations, with an average time-to-value of just 48 days.
The Series B proceeds will be used to expand product capabilities, grow engineering and deployment teams, and support a growing base of enterprise health system customers.
With health systems increasingly looking beyond task-specific bots and toward integrated AI infrastructure, Luminai’s latest raise reflects the broader momentum behind intelligent automation as a foundational layer in the future of healthcare operations.
As conversations around AI in healthcare continue to shift from experimentation to real-world deployment, these themes will be explored at MedTech World North America 2026. Taking place in West Palm Beach from May 11 to 13, 2026, the panel “Beyond the Algorithm — How AI is Being Built, Powered & Deployed in Healthcare” will examine what it truly takes to build clinical-grade AI, power it at scale, and support adoption across health systems. From validation and trust to compute infrastructure and enterprise implementation, leaders from across the AI and healthcare stack will share what the industry is still getting wrong, and what getting it right looks like.
Book your ticket now to be part of MedTech World North America 2026.
